Latest News & Features
Americas
Andrulis Pharmaceuticals Corp has accused Celgene Corp of infringing and inducing the infringement of one of its patents related to a method of treating cancer. 8 October 2013
Americas
Personal genomics company 23andMe has received a patent covering its Family Traits Inheritance Calculator tool that lets prospective parents see what traits their children may inherit. 8 October 2013
Europe
Teva Pharmaceutical Industries has claimed victory in a patent revocation action brought by generic drug maker Mylan in the Hague over its blockbuster Copaxone drug, used in the treatment of multiple sclerosis. 4 October 2013
article
Swedish law firm Vinge has hired IP specialist Ulf Dahlgren to its Stockholm office from rivals Lindahl, following Håkan Borgenhäll’s move from the same firm in April. 3 October 2013
Americas
Mylan Inc will be forced to divest injectable generic drugs before it can complete a proposed $1.85 billion acquisition of Agila Specialities Global Pte Ltd and Agila Specialties Pvt Ltd after the FTC applied conditions to the deal. 2 October 2013
Americas
US law firm Baker Botts has expanded its Houston office with the addition of IP litigator Nicolas Barzoukas. 1 October 2013
Americas
India’s drug patent policy has been slammed by US companies who are insisting that action be taken in order to improve trade relations. 30 September 2013
Americas
A federal judge has denied AstraZeneca’s motions to dismiss claims challenging its pay-for-delay deals with three generic pharmaceutical companies in connection to heartburn drug Nexium. 27 September 2013
Americas
A US company which provides secure personal medical records online has filed a patent infringement case against a rival health-care company. 26 September 2013
Big Pharma
The government in South Africa is considering changing its national policy on IP, a move that could have far reaching effects for its patents system. 26 September 2013